BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 24776713)

  • 1. What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research.
    Ibrahim K; Donyai P
    Atten Defic Hyperact Disord; 2018 Dec; 10(4):273-283. PubMed ID: 29982921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Methylphenidate During Inpatient Rehabilitation After Pediatric Traumatic Brain Injury: Population Characteristics and Prescribing Patterns.
    Caliendo E; Lowder R; McLaughlin MJ; Watson WD; Baum KT; Blackwell LS; Koterba CH; Hoskinson KR; Tlustos SJ; Shah SA; Suskauer SJ; Kurowski BG
    J Head Trauma Rehabil; 2024 May-Jun 01; 39(3):E122-E131. PubMed ID: 38709832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing for ADHD in primary care.
    Rashid A; Llanwarne N; Lehman R
    Br J Gen Pract; 2018 Apr; 68(669):170-171. PubMed ID: 29592923
    [No Abstract]   [Full Text] [Related]  

  • 4. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents.
    Polanczyk GV; Salum GA; Sugaya LS; Caye A; Rohde LA
    J Child Psychol Psychiatry; 2015 Mar; 56(3):345-65. PubMed ID: 25649325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of ADHD in children.
    Felt BT; Biermann B; Christner JG; Kochhar P; Harrison RV
    Am Fam Physician; 2014 Oct; 90(7):456-64. PubMed ID: 25369623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, diagnosis and treatment of ADHD in Arab and Jewish children in Israel, where are the gaps?
    Shehadeh-Sheeny A; Baron-Epel O
    BMC Psychiatry; 2023 Aug; 23(1):586. PubMed ID: 37568131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicine and supplement use in infants, children, and adolescents depends on sex, age, and socioeconomic status: results of a German longitudinal population-based cohort study (LIFE Child).
    Herzig M; Bertsche A; Kiess W; Bertsche T; Neininger MP
    Eur J Pediatr; 2022 Aug; 181(8):2991-3003. PubMed ID: 35614281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review.
    Kazda L; Bell K; Thomas R; McGeechan K; Sims R; Barratt A
    JAMA Netw Open; 2021 Apr; 4(4):e215335. PubMed ID: 33843998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of optimal treatment of ADHD in Israel: a suggestion for national policy.
    Ornoy A; Spivak A
    Health Econ Rev; 2019 Jul; 9(1):24. PubMed ID: 31289954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data.
    Bjerkeli PJ; Vicente RP; Mulinari S; Johnell K; Merlo J
    Clin Epidemiol; 2018; 10():1657-1665. PubMed ID: 30519114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade.
    Davidovitch M; Koren G; Fund N; Shrem M; Porath A
    BMC Pediatr; 2017 Dec; 17(1):218. PubMed ID: 29284437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention Deficit Hyperactivity Disorder Symptoms and Low Educational Achievement: Evidence Supporting A Causal Hypothesis.
    de Zeeuw EL; van Beijsterveldt CEM; Ehli EA; de Geus EJC; Boomsma DI
    Behav Genet; 2017 May; 47(3):278-289. PubMed ID: 28191586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to salient, dynamic sensory stimuli during development increases distractibility in adulthood.
    Hadas I; Gal R; Bokovza L; Meiran N; Feifel D; Zangen A
    Sci Rep; 2016 Feb; 6():21129. PubMed ID: 26882890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing Epidemiology of Methylphenidate Prescriptions in the Community: A Multifactorial Model.
    Jaber L; Rigler S; Shuper A; Diamond G
    J Atten Disord; 2017 Dec; 21(14):1143-1150. PubMed ID: 24776713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EPIDEMIOLOGY OF RITALIN PRESCRIPTION IN 6-18 YEARS OLD ISRAELI CHILDREN - TIME TO CHANGE POLICY].
    Jaber L; Rigler S; Shuper A; Diamond G
    Harefuah; 2017 Jul; 156(7):460-464. PubMed ID: 28786270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.
    Ehrhardt C; Boucherie Q; Pauly V; Braunstein D; Ronflé E; Thirion X; Frauger E; Micallef J
    Therapie; 2017 Dec; 72(6):635-641. PubMed ID: 29061293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences.
    Bogle KE; Smith BH
    Curr Drug Abuse Rev; 2009 May; 2(2):157-76. PubMed ID: 19630746
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.